Randomized Controlled Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer
Phase of Trial: Phase II
Latest Information Update: 09 Aug 2019
Price : $35 *
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Antineoplastics
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms MATEO
- 05 Aug 2019 Status changed from recruiting to completed.
- 11 Jun 2019 This trial has been Suspended in Germany, according to European Clinical Trials Database.
- 19 Feb 2019 Planned End Date changed from 1 Sep 2018 to 1 Jul 2020.